Alnylam业绩超预期但股价下跌，因美国Amvuttra和Onpattro销售增长放缓
· seekingalpha.com
Alnylam三季度业绩超预期后股价暴跌，因美国Amvuttra需求放缓且成本上升。更多详情请点击此处。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...